Iowa City Hypertension (High Blood Pressure)
Inclusion:
- Male or female ages Age ≥ 21
- Average of last 3 blood pressure readings for Non-Diabetics systolic blood pressure of 140-179 or diastolic blood pressure of 90-109, Diabetics systolic blood pressure of 130-179 or diastolic blood pressure of 80-109
- Currently on 0-3 blood pressure meds
Exclusion:
- MI (heart attack) in past 6 months
- Class III-IV CHF (congestive heart failure)
- Dementia
- Systolic blood pressure >180 or diastolic blood pressure >110
Benefits of participation in the study:
- $100.00 for 3 visits over 6 months
- Two 24 hour blood pressure readings
Study only open to patients from NEIFPC. If you are interested in this study contact Pam Trenkamp, Study Coordinator, at 319-272-2523
Failed Oral Treatment (Diabetes- Type II) (insulin-Lantus vs Lispro)
Inclusion:
- Male or female ages 30 thru 79 years
- At least 90 days of 2 oral meds (at least ½ max dose for both)
- A1c 7.2%-12%
Exclusion:
- Prior insulin use
- Have taken precose, glyset, symlin, byetta, starlix, or prandin in the past 6 weeks
Benefits of participation in the study:
- $720 for 15 visits over 2 ½ years
- Free oral diabetic study medications that you are currently taking
- Free study related medication, labs, ECG's, physicals and diabetic testing supplies
If you are interested in this study contact Angie Bixby-Ellermann, Study Coordinator, at 319-272-2536
Failed Diet/Exercise (Diabetes- Type II) (Metformin vs Avandamet)
Inclusion:
- Male or female ages 18-75 years
- Currently treated with diet/exercise only
- BMI(body mass index) >25
- A1c ≥ 7.5% to ≥ 10.5% at pre-screening visit
Exclusion:
- Have taken oral diabetic medication or insulin in the past 6 months for more than 14 days
- Systolic blood pressure >160, diastolic blood pressure of >90
Benefits of participation in the study:
- $665.00 for 13 visits over 82 weeks
- Free study medication, diabetic testing supplies, study related lab work, ECGs and physicals
If you are interested in this study contact Angie Bixby-Ellermann, Study Coordinator, at 319-272-2536
Osteoarthritis
(naproxen vs celecoxib vs ibuprofen, everyone provided with 20 or 40 mg Nexium)
Inclusion:
- Male or female ≥ 18 years of age
- Osteoarthritis or rheumatoid arthritis for at least the past 6 months
- Have required chronic (daily use) of pain medication for at least 6 months
- Established cardiovascular disease or high risk factors for cardiovascular disease
Exclusion:
- Acute joint trauma with active symptoms that may interfere
- Current use of oral corticosteroids(>20 mg prednisone or equivalent per day)
- History of GI perforation, obstruction or bleeding within last 6 months
- Cancer in the last 5 years
- Need for warfarin (Coumadin)
Benefits of participation in the study:
- $300.00 for 13 visits over 42 months, plus free Nexium
- Free study medication, study related lab work, physicals and ECG's
If you are interested in this study contact Angie Bixby-Ellermann, Study Coordinator, at 319-272-2536
Bacterial Conjunctivitis (Pink eye) (Placebo vs 0.6% ISV-403)
Inclusion:
- Male or female ≥ 1 year old
- Must have clinical diagnosis of acute bacterial conjunctivitis and exhibit purulent conjunctival discharge (crusty/sticky eyelids and redness)
Exclusion:
- Use of topical ophthalmic solution including tear substitutes within 2 hours of entry to the study
- Use of antibiotics within 72 hours of entry to the study
- Ocular surgery in the past 6 weeks
Benefits of participation in the study:
- $225.00 for 3 visits over 8 days
- Free study medication, study related lab work
If you are interested in this study contact Pam Trenkamp, Study Coordinator, at 319-272-2523